<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20240205150914&amp;utm_medium=rss&amp;v=2.18.0&amp;fc=20230708114047
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20240205150914&amp;utm_medium=rss&amp;v=2.18.0&amp;fc=20230708114047" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0)</generator>
<language>en</language>
<lastbuilddate>Mon, 05 Feb 2024 20:09:15 +0000</lastbuilddate>
<pubDate>Mon, 05 Feb 2024 06:00:00 -0500</pubDate>
<ttl>120</ttl>
<item>
<title>Blood pressure variability: no longer a mASCOT for research nerds</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38315171/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240205150914&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Feb 5:ehae023. doi: 10.1093/eurheartj/ehae023. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38315171/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240205150914&v=2.18.0">38315171</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae023>10.1093/eurheartj/ehae023</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38315171</guid>
<pubDate>Mon, 05 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Gianfranco Parati</dc:creator>
<dc:creator>Alessandro Croce</dc:creator>
<dc:creator>Grzegorz Bilo</dc:creator>
<dc:date>2024-02-05</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Blood pressure variability: no longer a mASCOT for research nerds</dc:title>
<dc:identifier>pmid:38315171</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae023</dc:identifier>
</item>
<item>
<title>Inactivation of Malic Enzyme 1 in Endothelial Cells Alleviates Pulmonary Hypertension</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38314588/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240205150914&amp;v=2.18.0
      <description>CONCLUSIONS: Our findings indicate that ME1 upregulation in endothelial cells plays a causative role in PH development by negatively regulating adenosine production and subsequently dysregulating endothelial functions. Our findings also suggest that ME1 may represent as a novel pharmacological target for upregulating protective adenosine signaling in PH therapy.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Feb 5. doi: 10.1161/CIRCULATIONAHA.123.067579. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Pulmonary hypertension (PH) is a progressive cardiopulmonary disease with a high mortality rate. Although growing evidence has revealed the importance of dysregulated energetic metabolism in the pathogenesis of PH, the underlying cellular and molecular mechanisms are not fully understood. In this study, we focused on ME1 (malic enzyme 1), a key enzyme linking glycolysis to the tricarboxylic acid cycle. We aimed to determine the role and mechanistic action of ME1 in PH.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Global and endothelial-specific <i>ME1</i> knockout mice were used to investigate the role of ME1 in hypoxia- and SU5416/hypoxia (SuHx)-induced PH. Small hairpin RNA and ME1 enzymatic inhibitor (ME1*) were used to study the mechanism of ME1 in pulmonary artery endothelial cells. Downstream key metabolic pathways and mediators of ME1 were identified by metabolomics analysis in vivo and ME1-mediated energetic alterations were examined by Seahorse metabolic analysis in vitro. The pharmacological effect of ME1* on PH treatment was evaluated in PH animal models induced by SuHx.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: We found that ME1 protein level and enzymatic activity were highly elevated in lung tissues of patients and mice with PH, primarily in vascular endothelial cells. Global knockout of <i>ME1</i> protected mice from developing hypoxia- or SuHx-induced PH. Endothelial-specific <i>ME1</i> deletion similarly attenuated pulmonary vascular remodeling and PH development in mice, suggesting a critical role of endothelial ME1 in PH. Mechanistic studies revealed that ME1 inhibition promoted downstream adenosine production and activated A<sub>2A</sub>R-mediated adenosine signaling, which leads to an increase in nitric oxide generation and a decrease in proinflammatory molecule expression in endothelial cells. ME1 inhibition activated adenosine production in an ATP-dependent manner through regulating malate-aspartate NADH (nicotinamide adenine dinucleotide plus hydrogen) shuttle and thereby balancing oxidative phosphorylation and glycolysis. Pharmacological inactivation of ME1 attenuated the progression of PH in both preventive and therapeutic settings by promoting adenosine production in vivo.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Our findings indicate that ME1 upregulation in endothelial cells plays a causative role in PH development by negatively regulating adenosine production and subsequently dysregulating endothelial functions. Our findings also suggest that ME1 may represent as a novel pharmacological target for upregulating protective adenosine signaling in PH therapy.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38314588/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240205150914&v=2.18.0">38314588</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067579>10.1161/CIRCULATIONAHA.123.067579</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38314588</guid>
<pubDate>Mon, 05 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Ya Luo</dc:creator>
<dc:creator>Xianmei Qi</dc:creator>
<dc:creator>Zhenxi Zhang</dc:creator>
<dc:creator>Jiawei Zhang</dc:creator>
<dc:creator>Bolun Li</dc:creator>
<dc:creator>Ting Shu</dc:creator>
<dc:creator>Xiaona Li</dc:creator>
<dc:creator>Huiyuan Hu</dc:creator>
<dc:creator>Jinqiu Li</dc:creator>
<dc:creator>Qihao Tang</dc:creator>
<dc:creator>Yitian Zhou</dc:creator>
<dc:creator>Mingyao Wang</dc:creator>
<dc:creator>Tianfei Fan</dc:creator>
<dc:creator>Wenjun Guo</dc:creator>
<dc:creator>Ying Liu</dc:creator>
<dc:creator>Jin Zhang</dc:creator>
<dc:creator>Junling Pang</dc:creator>
<dc:creator>Peiran Yang</dc:creator>
<dc:creator>Ran Gao</dc:creator>
<dc:creator>Wenhui Chen</dc:creator>
<dc:creator>Chen Yan</dc:creator>
<dc:creator>Yanjiang Xing</dc:creator>
<dc:creator>Wenjing Du</dc:creator>
<dc:creator>Jing Wang</dc:creator>
<dc:creator>Chen Wang</dc:creator>
<dc:date>2024-02-05</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Inactivation of Malic Enzyme 1 in Endothelial Cells Alleviates Pulmonary Hypertension</dc:title>
<dc:identifier>pmid:38314588</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067579</dc:identifier>
</item>
<item>
<title>Pediatric ECG-Based Deep Learning to Predict Left Ventricular Dysfunction and Remodeling</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38314583/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240205150914&amp;v=2.18.0
      <description>CONCLUSIONS: This externally validated algorithm shows promise to inexpensively screen for LV dysfunction and remodeling in children, which may facilitate improved access to care by democratizing the expertise of pediatric cardiologists.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Feb 5. doi: 10.1161/CIRCULATIONAHA.123.067750. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Artificial intelligence-enhanced ECG analysis shows promise to detect ventricular dysfunction and remodeling in adult populations. However, its application to pediatric populations remains underexplored.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A convolutional neural network was trained on paired ECG-echocardiograms (≤2 days apart) from patients ≤18 years of age without major congenital heart disease to detect human expert-classified greater than mild left ventricular (LV) dysfunction, hypertrophy, and dilation (individually and as a composite outcome). Model performance was evaluated on single ECG-echocardiogram pairs per patient at Boston Children's Hospital and externally at Mount Sinai Hospital using area under the receiver operating characteristic curve (AUROC) and area under the precision-recall curve (AUPRC).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The training cohort comprised 92 377 ECG-echocardiogram pairs (46 261 patients; median age, 8.2 years). Test groups included internal testing (12 631 patients; median age, 8.8 years; 4.6% composite outcomes), emergency department (2830 patients; median age, 7.7 years; 10.0% composite outcomes), and external validation (5088 patients; median age, 4.3 years; 6.1% composite outcomes) cohorts. Model performance was similar on internal test and emergency department cohorts, with model predictions of LV hypertrophy outperforming the pediatric cardiologist expert benchmark. Adding age and sex to the model added no benefit to model performance. When using quantitative outcome cutoffs, model performance was similar between internal testing (composite outcome: AUROC, 0.88, AUPRC, 0.43; LV dysfunction: AUROC, 0.92, AUPRC, 0.23; LV hypertrophy: AUROC, 0.88, AUPRC, 0.28; LV dilation: AUROC, 0.91, AUPRC, 0.47) and external validation (composite outcome: AUROC, 0.86, AUPRC, 0.39; LV dysfunction: AUROC, 0.94, AUPRC, 0.32; LV hypertrophy: AUROC, 0.84, AUPRC, 0.25; LV dilation: AUROC, 0.87, AUPRC, 0.33), with composite outcome negative predictive values of 99.0% and 99.2%, respectively. Saliency mapping highlighted ECG components that influenced model predictions (precordial QRS complexes for all outcomes; T waves for LV dysfunction). High-risk ECG features include lateral T-wave inversion (LV dysfunction), deep S waves in V1 and V2 and tall R waves in V5 and V6 (LV hypertrophy), and tall R waves in V4 through V6 (LV dilation).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: This externally validated algorithm shows promise to inexpensively screen for LV dysfunction and remodeling in children, which may facilitate improved access to care by democratizing the expertise of pediatric cardiologists.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38314583/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240205150914&v=2.18.0">38314583</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067750>10.1161/CIRCULATIONAHA.123.067750</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38314583</guid>
<pubDate>Mon, 05 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Joshua Mayourian</dc:creator>
<dc:creator>William G La Cava</dc:creator>
<dc:creator>Akhil Vaid</dc:creator>
<dc:creator>Girish N Nadkarni</dc:creator>
<dc:creator>Sunil J Ghelani</dc:creator>
<dc:creator>Rebekah Mannix</dc:creator>
<dc:creator>Tal Geva</dc:creator>
<dc:creator>Audrey Dionne</dc:creator>
<dc:creator>Mark E Alexander</dc:creator>
<dc:creator>Son Q Duong</dc:creator>
<dc:creator>John K Triedman</dc:creator>
<dc:date>2024-02-05</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Pediatric ECG-Based Deep Learning to Predict Left Ventricular Dysfunction and Remodeling</dc:title>
<dc:identifier>pmid:38314583</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067750</dc:identifier>
</item>
<item>
<title>A Galectin-9-Driven CD11c&lt;sup>;high&lt;/sup>; Decidual Macrophage Subset Suppresses Uterine Vascular Remodeling in Preeclampsia</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38314577/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240205150914&amp;v=2.18.0
      <description>CONCLUSIONS: These findings highlight a key role of a distinct perivascular inflammatory CD11c^(high) dMφ subpopulation in the pathogenesis of preeclampsia. CD11c^(high) dMφ activated by increased galectin-9 from trophoblasts suppresses uterine spiral artery remodeling, contributing to preeclampsia. Increased circulating galectin-9 may be a biomarker for preeclampsia prediction and intervention.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Feb 5. doi: 10.1161/CIRCULATIONAHA.123.064391. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Preeclampsia is a serious disease of pregnancy that lacks early diagnosis methods or effective treatment, except delivery. Dysregulated uterine immune cells and spiral arteries are implicated in preeclampsia, but the mechanistic link remains unclear.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Single-cell RNA sequencing and spatial transcriptomics were used to identify immune cell subsets associated with preeclampsia. Cell-based studies and animal models including conditional knockout mice and a new preeclampsia mouse model induced by recombinant mouse galectin-9 were applied to validate the pathogenic role of a CD11c<sup>high</sup> subpopulation of decidual macrophages (dMφ) and to determine its underlying regulatory mechanisms in preeclampsia. A retrospective preeclampsia cohort study was performed to determine the value of circulating galectin-9 in predicting preeclampsia.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: We discovered a distinct CD11c<sup>high</sup> dMφ subset that inhibits spiral artery remodeling in preeclampsia. The proinflammatory CD11c<sup>high</sup> dMφ exhibits perivascular enrichment in the decidua from patients with preeclampsia. We also showed that trophoblast-derived galectin-9 activates CD11c<sup>high</sup> dMφ by means of CD44 binding to suppress spiral artery remodeling. In 3 independent preeclampsia mouse models, placental and plasma galectin-9 levels were elevated. Galectin-9 administration in mice induces preeclampsia-like phenotypes with increased CD11c<sup>high</sup> dMφ and defective spiral arteries, whereas galectin-9 blockade or macrophage-specific CD44 deletion prevents such phenotypes. In pregnant women, increased circulating galectin-9 levels in the first trimester and at 16 to 20 gestational weeks can predict subsequent preeclampsia onset.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: These findings highlight a key role of a distinct perivascular inflammatory CD11c<sup>high</sup> dMφ subpopulation in the pathogenesis of preeclampsia. CD11c<sup>high</sup> dMφ activated by increased galectin-9 from trophoblasts suppresses uterine spiral artery remodeling, contributing to preeclampsia. Increased circulating galectin-9 may be a biomarker for preeclampsia prediction and intervention.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38314577/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240205150914&v=2.18.0">38314577</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064391>10.1161/CIRCULATIONAHA.123.064391</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38314577</guid>
<pubDate>Mon, 05 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Yanhong Li</dc:creator>
<dc:creator>Yifei Sang</dc:creator>
<dc:creator>Yunjian Chang</dc:creator>
<dc:creator>Chunfang Xu</dc:creator>
<dc:creator>Yikong Lin</dc:creator>
<dc:creator>Yao Zhang</dc:creator>
<dc:creator>Philip C N Chiu</dc:creator>
<dc:creator>William S B Yeung</dc:creator>
<dc:creator>Haisheng Zhou</dc:creator>
<dc:creator>Ningzheng Dong</dc:creator>
<dc:creator>Ling Xu</dc:creator>
<dc:creator>Jiajia Chen</dc:creator>
<dc:creator>Weijie Zhao</dc:creator>
<dc:creator>Lu Liu</dc:creator>
<dc:creator>Di Yu</dc:creator>
<dc:creator>Xingxing Zang</dc:creator>
<dc:creator>Jiangfeng Ye</dc:creator>
<dc:creator>Jinying Yang</dc:creator>
<dc:creator>Qingyu Wu</dc:creator>
<dc:creator>Dajin Li</dc:creator>
<dc:creator>Ligang Wu</dc:creator>
<dc:creator>Meirong Du</dc:creator>
<dc:date>2024-02-05</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>A Galectin-9-Driven CD11c&lt;sup>;high&lt;/sup>; Decidual Macrophage Subset Suppresses Uterine Vascular Remodeling in Preeclampsia</dc:title>
<dc:identifier>pmid:38314577</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.064391</dc:identifier>
</item>
<item>
<title>Pharmacological Management of Cardiac Arrhythmias in the Fetal and Neonatal Periods: A Scientific Statement From the American Heart Association: Endorsed by the Pediatric &amp;amp; Congenital Electrophysiology Society (PACES)</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38314551/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240205150914&amp;v=2.18.0
      <description>Disorders of the cardiac rhythm may occur in both the fetus and neonate. Because of the immature myocardium, the hemodynamic consequences of either bradyarrhythmias or tachyarrhythmias may be far more significant than in mature physiological states. Treatment options are limited in the fetus and neonate because of limited vascular access, patient size, and the significant risk/benefit ratio of any intervention. In addition, exposure of the fetus or neonate to either persistent arrhythmias or...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Feb 5. doi: 10.1161/CIR.0000000000001206. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Disorders of the cardiac rhythm may occur in both the fetus and neonate. Because of the immature myocardium, the hemodynamic consequences of either bradyarrhythmias or tachyarrhythmias may be far more significant than in mature physiological states. Treatment options are limited in the fetus and neonate because of limited vascular access, patient size, and the significant risk/benefit ratio of any intervention. In addition, exposure of the fetus or neonate to either persistent arrhythmias or antiarrhythmic medications may have yet-to-be-determined long-term developmental consequences. This scientific statement discusses the mechanism of arrhythmias, pharmacological treatment options, and distinct aspects of pharmacokinetics for the fetus and neonate. From the available current data, subjects of apparent consistency/consensus are presented, as well as future directions for research in terms of aspects of care for which evidence has not been established.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38314551/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240205150914&v=2.18.0">38314551</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001206>10.1161/CIR.0000000000001206</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38314551</guid>
<pubDate>Mon, 05 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Anjan S Batra</dc:creator>
<dc:creator>Michael J Silka</dc:creator>
<dc:creator>Alejandro Borquez</dc:creator>
<dc:creator>Bettina Cuneo</dc:creator>
<dc:creator>Brynn Dechert</dc:creator>
<dc:creator>Edgar Jaeggi</dc:creator>
<dc:creator>Prince J Kannankeril</dc:creator>
<dc:creator>Christine Tabulov</dc:creator>
<dc:creator>James E Tisdale</dc:creator>
<dc:creator>Diana Wolfe</dc:creator>
<dc:creator>American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology, Council on Basic Cardiovascular Sciences, Council on Cardiovascular and Stroke Nursing, Council on Genomic and Precision Medicine, and Council on Lifelong Congenital Heart Disease and Heart Health in the Young</dc:creator>
<dc:date>2024-02-05</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Pharmacological Management of Cardiac Arrhythmias in the Fetal and Neonatal Periods: A Scientific Statement From the American Heart Association: Endorsed by the Pediatric &amp;amp; Congenital Electrophysiology Society (PACES)</dc:title>
<dc:identifier>pmid:38314551</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001206</dc:identifier>
</item>
<item>
<title>Microglia maintain structural integrity during fetal brain morphogenesis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38309258/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240205150914&amp;v=2.18.0
      <description>Microglia (MG), the brain-resident macrophages, play major roles in health and disease via a diversity of cellular states. While embryonic MG display a large heterogeneity of cellular distribution and transcriptomic states, their functions remain poorly characterized. Here, we uncovered a role for MG in the maintenance of structural integrity at two fetal cortical boundaries. At these boundaries between structures that grow in distinct directions, embryonic MG accumulate, display a state...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jan 31:S0092-8674(24)00044-8. doi: 10.1016/j.cell.2024.01.012. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Microglia (MG), the brain-resident macrophages, play major roles in health and disease via a diversity of cellular states. While embryonic MG display a large heterogeneity of cellular distribution and transcriptomic states, their functions remain poorly characterized. Here, we uncovered a role for MG in the maintenance of structural integrity at two fetal cortical boundaries. At these boundaries between structures that grow in distinct directions, embryonic MG accumulate, display a state resembling post-natal axon-tract-associated microglia (ATM) and prevent the progression of microcavities into large cavitary lesions, in part via a mechanism involving the ATM-factor Spp1. MG and Spp1 furthermore contribute to the rapid repair of lesions, collectively highlighting protective functions that preserve the fetal brain from physiological morphogenetic stress and injury. Our study thus highlights key major roles for embryonic MG and Spp1 in maintaining structural integrity during morphogenesis, with major implications for our understanding of MG functions and brain development.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38309258/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240205150914&v=2.18.0">38309258</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.01.012>10.1016/j.cell.2024.01.012</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38309258</guid>
<pubDate>Sat, 03 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Akindé René Lawrence</dc:creator>
<dc:creator>Alice Canzi</dc:creator>
<dc:creator>Cécile Bridlance</dc:creator>
<dc:creator>Nicolas Olivié</dc:creator>
<dc:creator>Claire Lansonneur</dc:creator>
<dc:creator>Clarissa Catale</dc:creator>
<dc:creator>Lara Pizzamiglio</dc:creator>
<dc:creator>Benoit Kloeckner</dc:creator>
<dc:creator>Aymeric Silvin</dc:creator>
<dc:creator>David A D Munro</dc:creator>
<dc:creator>Aurélien Fortoul</dc:creator>
<dc:creator>Davide Boido</dc:creator>
<dc:creator>Feriel Zehani</dc:creator>
<dc:creator>Hugues Cartonnet</dc:creator>
<dc:creator>Sarah Viguier</dc:creator>
<dc:creator>Guillaume Oller</dc:creator>
<dc:creator>Paola Squarzoni</dc:creator>
<dc:creator>Adrien Candat</dc:creator>
<dc:creator>Julie Helft</dc:creator>
<dc:creator>Cécile Allet</dc:creator>
<dc:creator>Francoise Watrin</dc:creator>
<dc:creator>Jean-Bernard Manent</dc:creator>
<dc:creator>Pierre Paoletti</dc:creator>
<dc:creator>Denis Thieffry</dc:creator>
<dc:creator>Laura Cantini</dc:creator>
<dc:creator>Clare Pridans</dc:creator>
<dc:creator>Josef Priller</dc:creator>
<dc:creator>Antoinette Gélot</dc:creator>
<dc:creator>Paolo Giacobini</dc:creator>
<dc:creator>Luisa Ciobanu</dc:creator>
<dc:creator>Florent Ginhoux</dc:creator>
<dc:creator>Morgane Sonia Thion</dc:creator>
<dc:creator>Ludmilla Lokmane</dc:creator>
<dc:creator>Sonia Garel</dc:creator>
<dc:date>2024-02-03</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Microglia maintain structural integrity during fetal brain morphogenesis</dc:title>
<dc:identifier>pmid:38309258</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.01.012</dc:identifier>
</item>
<item>
<title>A multi-tissue metabolome atlas of primate pregnancy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38306985/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240205150914&amp;v=2.18.0
      <description>Pregnancy induces dramatic metabolic changes in females; yet, the intricacies of this metabolic reprogramming remain poorly understood, especially in primates. Using cynomolgus monkeys, we constructed a comprehensive multi-tissue metabolome atlas, analyzing 273 samples from 23 maternal tissues during pregnancy. We discovered a decline in metabolic coupling between tissues as pregnancy progressed. Core metabolic pathways that were rewired during primate pregnancy included steroidogenesis, fatty...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Feb 1;187(3):764-781.e14. doi: 10.1016/j.cell.2023.11.043.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Pregnancy induces dramatic metabolic changes in females; yet, the intricacies of this metabolic reprogramming remain poorly understood, especially in primates. Using cynomolgus monkeys, we constructed a comprehensive multi-tissue metabolome atlas, analyzing 273 samples from 23 maternal tissues during pregnancy. We discovered a decline in metabolic coupling between tissues as pregnancy progressed. Core metabolic pathways that were rewired during primate pregnancy included steroidogenesis, fatty acid metabolism, and arachidonic acid metabolism. Our atlas revealed 91 pregnancy-adaptive metabolites changing consistently across 23 tissues, whose roles we verified in human cell models and patient samples. Corticosterone and palmitoyl-carnitine regulated placental maturation and maternal tissue progenitors, respectively, with implications for maternal preeclampsia, diabetes, cardiac hypertrophy, and muscle and liver regeneration. Moreover, we found that corticosterone deficiency induced preeclampsia-like inflammation, indicating the atlas's potential clinical value. Overall, our multi-tissue metabolome atlas serves as a framework for elucidating the role of metabolic regulation in female health during pregnancy.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38306985/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240205150914&v=2.18.0">38306985</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.11.043>10.1016/j.cell.2023.11.043</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38306985</guid>
<pubDate>Fri, 02 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Dainan Yu</dc:creator>
<dc:creator>Haifeng Wan</dc:creator>
<dc:creator>Chao Tong</dc:creator>
<dc:creator>Lu Guang</dc:creator>
<dc:creator>Gang Chen</dc:creator>
<dc:creator>Jiali Su</dc:creator>
<dc:creator>Lan Zhang</dc:creator>
<dc:creator>Yue Wang</dc:creator>
<dc:creator>Zhenyu Xiao</dc:creator>
<dc:creator>Jinglei Zhai</dc:creator>
<dc:creator>Long Yan</dc:creator>
<dc:creator>Wenwu Ma</dc:creator>
<dc:creator>Kun Liang</dc:creator>
<dc:creator>Taoyan Liu</dc:creator>
<dc:creator>Yuefan Wang</dc:creator>
<dc:creator>Zehang Peng</dc:creator>
<dc:creator>Lanfang Luo</dc:creator>
<dc:creator>Ruoxuan Yu</dc:creator>
<dc:creator>Wei Li</dc:creator>
<dc:creator>Hongbo Qi</dc:creator>
<dc:creator>Hongmei Wang</dc:creator>
<dc:creator>Ng Shyh-Chang</dc:creator>
<dc:date>2024-02-02</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A multi-tissue metabolome atlas of primate pregnancy</dc:title>
<dc:identifier>pmid:38306985</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.11.043</dc:identifier>
</item>
<item>
<title>Xist ribonucleoproteins promote female sex-biased autoimmunity</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38306984/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240205150914&amp;v=2.18.0
      <description>Autoimmune diseases disproportionately affect females more than males. The XX sex chromosome complement is strongly associated with susceptibility to autoimmunity. Xist long non-coding RNA (lncRNA) is expressed only in females to randomly inactivate one of the two X chromosomes to achieve gene dosage compensation. Here, we show that the Xist ribonucleoprotein (RNP) complex comprising numerous autoantigenic components is an important driver of sex-biased autoimmunity. Inducible transgenic...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Feb 1;187(3):733-749.e16. doi: 10.1016/j.cell.2023.12.037.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Autoimmune diseases disproportionately affect females more than males. The XX sex chromosome complement is strongly associated with susceptibility to autoimmunity. Xist long non-coding RNA (lncRNA) is expressed only in females to randomly inactivate one of the two X chromosomes to achieve gene dosage compensation. Here, we show that the Xist ribonucleoprotein (RNP) complex comprising numerous autoantigenic components is an important driver of sex-biased autoimmunity. Inducible transgenic expression of a non-silencing form of Xist in male mice introduced Xist RNP complexes and sufficed to produce autoantibodies. Male SJL/J mice expressing transgenic Xist developed more severe multi-organ pathology in a pristane-induced lupus model than wild-type males. Xist expression in males reprogrammed T and B cell populations and chromatin states to more resemble wild-type females. Human patients with autoimmune diseases displayed significant autoantibodies to multiple components of XIST RNP. Thus, a sex-specific lncRNA scaffolds ubiquitous RNP components to drive sex-biased immunity.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38306984/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240205150914&v=2.18.0">38306984</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.12.037>10.1016/j.cell.2023.12.037</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38306984</guid>
<pubDate>Fri, 02 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Diana R Dou</dc:creator>
<dc:creator>Yanding Zhao</dc:creator>
<dc:creator>Julia A Belk</dc:creator>
<dc:creator>Yang Zhao</dc:creator>
<dc:creator>Kerriann M Casey</dc:creator>
<dc:creator>Derek C Chen</dc:creator>
<dc:creator>Rui Li</dc:creator>
<dc:creator>Bingfei Yu</dc:creator>
<dc:creator>Suhas Srinivasan</dc:creator>
<dc:creator>Brian T Abe</dc:creator>
<dc:creator>Katerina Kraft</dc:creator>
<dc:creator>Ceke Hellström</dc:creator>
<dc:creator>Ronald Sjöberg</dc:creator>
<dc:creator>Sarah Chang</dc:creator>
<dc:creator>Allan Feng</dc:creator>
<dc:creator>Daniel W Goldman</dc:creator>
<dc:creator>Ami A Shah</dc:creator>
<dc:creator>Michelle Petri</dc:creator>
<dc:creator>Lorinda S Chung</dc:creator>
<dc:creator>David F Fiorentino</dc:creator>
<dc:creator>Emma K Lundberg</dc:creator>
<dc:creator>Anton Wutz</dc:creator>
<dc:creator>Paul J Utz</dc:creator>
<dc:creator>Howard Y Chang</dc:creator>
<dc:date>2024-02-02</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Xist ribonucleoproteins promote female sex-biased autoimmunity</dc:title>
<dc:identifier>pmid:38306984</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.12.037</dc:identifier>
</item>
<item>
<title>Brain-wide neural activity underlying memory-guided movement</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38306983/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240205150914&amp;v=2.18.0
      <description>Behavior relies on activity in structured neural circuits that are distributed across the brain, but most experiments probe neurons in a single area at a time. Using multiple Neuropixels probes, we recorded from multi-regional loops connected to the anterior lateral motor cortex (ALM), a circuit node mediating memory-guided directional licking. Neurons encoding sensory stimuli, choices, and actions were distributed across the brain. However, choice coding was concentrated in the ALM and...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Feb 1;187(3):676-691.e16. doi: 10.1016/j.cell.2023.12.035.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Behavior relies on activity in structured neural circuits that are distributed across the brain, but most experiments probe neurons in a single area at a time. Using multiple Neuropixels probes, we recorded from multi-regional loops connected to the anterior lateral motor cortex (ALM), a circuit node mediating memory-guided directional licking. Neurons encoding sensory stimuli, choices, and actions were distributed across the brain. However, choice coding was concentrated in the ALM and subcortical areas receiving input from the ALM in an ALM-dependent manner. Diverse orofacial movements were encoded in the hindbrain; midbrain; and, to a lesser extent, forebrain. Choice signals were first detected in the ALM and the midbrain, followed by the thalamus and other brain areas. At movement initiation, choice-selective activity collapsed across the brain, followed by new activity patterns driving specific actions. Our experiments provide the foundation for neural circuit models of decision-making and movement initiation.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38306983/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240205150914&v=2.18.0">38306983</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.12.035>10.1016/j.cell.2023.12.035</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38306983</guid>
<pubDate>Fri, 02 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Susu Chen</dc:creator>
<dc:creator>Yi Liu</dc:creator>
<dc:creator>Ziyue Aiden Wang</dc:creator>
<dc:creator>Jennifer Colonell</dc:creator>
<dc:creator>Liu D Liu</dc:creator>
<dc:creator>Han Hou</dc:creator>
<dc:creator>Nai-Wen Tien</dc:creator>
<dc:creator>Tim Wang</dc:creator>
<dc:creator>Timothy Harris</dc:creator>
<dc:creator>Shaul Druckmann</dc:creator>
<dc:creator>Nuo Li</dc:creator>
<dc:creator>Karel Svoboda</dc:creator>
<dc:date>2024-02-02</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Brain-wide neural activity underlying memory-guided movement</dc:title>
<dc:identifier>pmid:38306983</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.12.035</dc:identifier>
</item>
<item>
<title>Integrating cellular electron microscopy with multimodal data to explore biology across space and time</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38306982/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240205150914&amp;v=2.18.0
      <description>Biology spans a continuum of length and time scales. Individual experimental methods only glimpse discrete pieces of this spectrum but can be combined to construct a more holistic view. In this Review, we detail the latest advancements in volume electron microscopy (vEM) and cryo-electron tomography (cryo-ET), which together can visualize biological complexity across scales from the organization of cells in large tissues to the molecular details inside native cellular environments. In addition,...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Feb 1;187(3):563-584. doi: 10.1016/j.cell.2024.01.005.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Biology spans a continuum of length and time scales. Individual experimental methods only glimpse discrete pieces of this spectrum but can be combined to construct a more holistic view. In this Review, we detail the latest advancements in volume electron microscopy (vEM) and cryo-electron tomography (cryo-ET), which together can visualize biological complexity across scales from the organization of cells in large tissues to the molecular details inside native cellular environments. In addition, we discuss emerging methodologies for integrating three-dimensional electron microscopy (3DEM) imaging with multimodal data, including fluorescence microscopy, mass spectrometry, single-particle analysis, and AI-based structure prediction. This multifaceted approach fills gaps in the biological continuum, providing functional context, spatial organization, molecular identity, and native interactions. We conclude with a perspective on incorporating diverse data into computational simulations that further bridge and extend length scales while integrating the dimension of time.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38306982/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240205150914&v=2.18.0">38306982</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.01.005>10.1016/j.cell.2024.01.005</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38306982</guid>
<pubDate>Fri, 02 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Caitlyn L McCafferty</dc:creator>
<dc:creator>Sven Klumpe</dc:creator>
<dc:creator>Rommie E Amaro</dc:creator>
<dc:creator>Wanda Kukulski</dc:creator>
<dc:creator>Lucy Collinson</dc:creator>
<dc:creator>Benjamin D Engel</dc:creator>
<dc:date>2024-02-02</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Integrating cellular electron microscopy with multimodal data to explore biology across space and time</dc:title>
<dc:identifier>pmid:38306982</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.01.005</dc:identifier>
</item>
<item>
<title>Understanding the cell: Future views of structural biology</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38306981/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240205150914&amp;v=2.18.0
      <description>Determining the structure and mechanisms of all individual functional modules of cells at high molecular detail has often been seen as equal to understanding how cells work. Recent technical advances have led to a flush of high-resolution structures of various macromolecular machines, but despite this wealth of detailed information, our understanding of cellular function remains incomplete. Here, we discuss present-day limitations of structural biology and highlight novel technologies that may...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Feb 1;187(3):545-562. doi: 10.1016/j.cell.2023.12.017.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Determining the structure and mechanisms of all individual functional modules of cells at high molecular detail has often been seen as equal to understanding how cells work. Recent technical advances have led to a flush of high-resolution structures of various macromolecular machines, but despite this wealth of detailed information, our understanding of cellular function remains incomplete. Here, we discuss present-day limitations of structural biology and highlight novel technologies that may enable us to analyze molecular functions directly inside cells. We predict that the progression toward structural cell biology will involve a shift toward conceptualizing a 4D virtual reality of cells using digital twins. These will capture cellular segments in a highly enriched molecular detail, include dynamic changes, and facilitate simulations of molecular processes, leading to novel and experimentally testable predictions. Transferring biological questions into algorithms that learn from the existing wealth of data and explore novel solutions may ultimately unveil how cells work.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38306981/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240205150914&v=2.18.0">38306981</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.12.017>10.1016/j.cell.2023.12.017</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38306981</guid>
<pubDate>Fri, 02 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Martin Beck</dc:creator>
<dc:creator>Roberto Covino</dc:creator>
<dc:creator>Inga Hänelt</dc:creator>
<dc:creator>Michaela Müller-McNicoll</dc:creator>
<dc:date>2024-02-02</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Understanding the cell: Future views of structural biology</dc:title>
<dc:identifier>pmid:38306981</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.12.017</dc:identifier>
</item>
<item>
<title>De novo protein design-From new structures to programmable functions</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38306980/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240205150914&amp;v=2.18.0
      <description>Methods from artificial intelligence (AI) trained on large datasets of sequences and structures can now "write" proteins with new shapes and molecular functions de novo, without starting from proteins found in nature. In this Perspective, I will discuss the state of the field of de novo protein design at the juncture of physics-based modeling approaches and AI. New protein folds and higher-order assemblies can be designed with considerable experimental success rates, and difficult problems...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Feb 1;187(3):526-544. doi: 10.1016/j.cell.2023.12.028.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Methods from artificial intelligence (AI) trained on large datasets of sequences and structures can now "write" proteins with new shapes and molecular functions de novo, without starting from proteins found in nature. In this Perspective, I will discuss the state of the field of de novo protein design at the juncture of physics-based modeling approaches and AI. New protein folds and higher-order assemblies can be designed with considerable experimental success rates, and difficult problems requiring tunable control over protein conformations and precise shape complementarity for molecular recognition are coming into reach. Emerging approaches incorporate engineering principles-tunability, controllability, and modularity-into the design process from the beginning. Exciting frontiers lie in deconstructing cellular functions with de novo proteins and, conversely, constructing synthetic cellular signaling from the ground up. As methods improve, many more challenges are unsolved.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38306980/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240205150914&v=2.18.0">38306980</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.12.028>10.1016/j.cell.2023.12.028</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38306980</guid>
<pubDate>Fri, 02 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Tanja Kortemme</dc:creator>
<dc:date>2024-02-02</dc:date>
<dc:source>Cell</dc:source>
<dc:title>De novo protein design-From new structures to programmable functions</dc:title>
<dc:identifier>pmid:38306980</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.12.028</dc:identifier>
</item>
<item>
<title>Enabling structure-based drug discovery utilizing predicted models</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38306979/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240205150914&amp;v=2.18.0
      <description>High-quality predicted structures enable structure-based approaches to an expanding number of drug discovery programs. We propose that by utilizing free energy perturbation (FEP), predicted structures can be confidently employed to achieve drug design goals. We use structure-based modeling of hERG inhibition to illustrate this value of FEP.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Feb 1;187(3):521-525. doi: 10.1016/j.cell.2023.12.034.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">High-quality predicted structures enable structure-based approaches to an expanding number of drug discovery programs. We propose that by utilizing free energy perturbation (FEP), predicted structures can be confidently employed to achieve drug design goals. We use structure-based modeling of hERG inhibition to illustrate this value of FEP.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38306979/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240205150914&v=2.18.0">38306979</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.12.034>10.1016/j.cell.2023.12.034</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38306979</guid>
<pubDate>Fri, 02 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Edward B Miller</dc:creator>
<dc:creator>Howook Hwang</dc:creator>
<dc:creator>Mee Shelley</dc:creator>
<dc:creator>Andrew Placzek</dc:creator>
<dc:creator>João P G L M Rodrigues</dc:creator>
<dc:creator>Robert K Suto</dc:creator>
<dc:creator>Lingle Wang</dc:creator>
<dc:creator>Karen Akinsanya</dc:creator>
<dc:creator>Robert Abel</dc:creator>
<dc:date>2024-02-02</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Enabling structure-based drug discovery utilizing predicted models</dc:title>
<dc:identifier>pmid:38306979</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.12.034</dc:identifier>
</item>
<item>
<title>Structure is beauty, but not always truth</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38306978/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240205150914&amp;v=2.18.0
      <description>Structural biology, as powerful as it is, can be misleading. We highlight four fundamental challenges: interpreting raw experimental data; accounting for motion; addressing the misleading nature of in vitro structures; and unraveling interactions between drugs and "anti-targets." Overcoming these challenges will amplify the impact of structural biology on drug discovery.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Feb 1;187(3):517-520. doi: 10.1016/j.cell.2024.01.003.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Structural biology, as powerful as it is, can be misleading. We highlight four fundamental challenges: interpreting raw experimental data; accounting for motion; addressing the misleading nature of in vitro structures; and unraveling interactions between drugs and "anti-targets." Overcoming these challenges will amplify the impact of structural biology on drug discovery.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38306978/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240205150914&v=2.18.0">38306978</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.01.003>10.1016/j.cell.2024.01.003</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38306978</guid>
<pubDate>Fri, 02 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>James S Fraser</dc:creator>
<dc:creator>Mark A Murcko</dc:creator>
<dc:date>2024-02-02</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Structure is beauty, but not always truth</dc:title>
<dc:identifier>pmid:38306978</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.01.003</dc:identifier>
</item>
<item>
<title>Pursuing structural biology in China</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38306977/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240205150914&amp;v=2.18.0
      <description>In November 2023, structural biologists from different countries and different disciplines gathered at the Cell Symposium: Structural biology from the nanoscale to cellular mesoscale to discuss recent breakthroughs, including structures of proteins and macromolecular complexes in a cellular context as well as virus structures obtained by using different techniques. At the symposium, Cell editor Jia Cheng and Karin Kühnel, editor-in-chief of Structure, spoke with Drs. Beili Wu, Mingjie Zhang, and...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Feb 1;187(3):513-516. doi: 10.1016/j.cell.2023.12.031.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">In November 2023, structural biologists from different countries and different disciplines gathered at the Cell Symposium: Structural biology from the nanoscale to cellular mesoscale to discuss recent breakthroughs, including structures of proteins and macromolecular complexes in a cellular context as well as virus structures obtained by using different techniques. At the symposium, Cell editor Jia Cheng and Karin Kühnel, editor-in-chief of Structure, spoke with Drs. Beili Wu, Mingjie Zhang, and Zihe Rao about their experiences doing structural biology research in China and about their perspectives for the future. An edited transcript of the conversation is presented below, and the full conversation is available with the article online.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38306977/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240205150914&v=2.18.0">38306977</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.12.031>10.1016/j.cell.2023.12.031</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38306977</guid>
<pubDate>Fri, 02 Feb 2024 06:00:00 -0500</pubDate>
<dc:date>2024-02-02</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Pursuing structural biology in China</dc:title>
<dc:identifier>pmid:38306977</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.12.031</dc:identifier>
</item>
<item>
<title>Moving structural biology forward together</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38306976/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240205150914&amp;v=2.18.0
      <description>Continuing the celebration of Cell's 50th anniversary, this Focus Issue is an ode to the field of Structural Biology. We present Leading Edge articles highlighting specific approaches and insights that this field offers to answer fundamental and critical biological questions.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Feb 1;187(3):511-512. doi: 10.1016/j.cell.2024.01.006.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Continuing the celebration of Cell's 50th anniversary, this Focus Issue is an ode to the field of Structural Biology. We present Leading Edge articles highlighting specific approaches and insights that this field offers to answer fundamental and critical biological questions.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38306976/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240205150914&v=2.18.0">38306976</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.01.006>10.1016/j.cell.2024.01.006</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38306976</guid>
<pubDate>Fri, 02 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Cell Editorial Team</dc:creator>
<dc:date>2024-02-02</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Moving structural biology forward together</dc:title>
<dc:identifier>pmid:38306976</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.01.006</dc:identifier>
</item>
<item>
<title>Hypertensive disorders of pregnancy and cardiovascular disease risk: A Mendelian Randomisation study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38304335/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240205150914&amp;v=2.18.0
      <description>CONCLUSIONS: Genetic liability to HDPs is associated with higher CVD risk, lower blood pressure levels, and earlier hypertension diagnosis. Our study suggests similar findings in ever pregnant women, nulligravidae and men, implying biological mechanisms relating to HDPs are causally related to CVD risk.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Nov 9;44(Suppl 2):655.2726. doi: 10.1093/eurheartj/ehad655.2726.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: Observational studies show that hypertensive disorders of pregnancy (HDPs) are related to unfavourable maternal cardiovascular disease (CVD) risk profiles later in life. We investigated whether genetic liability to pre-eclampsia/eclampsia and gestational hypertension is associated with CVD risk factors and occurrence of CVD events.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We obtained genetic associations with HDPs from a genome-wide association study and used individual-participant-data from the UK Biobank to obtain genetic associations with CVD risk factors and CVD events (defined as myocardial infarction or stroke). In our primary analysis, we applied Mendelian Randomisation using inverse-variance weighted regression analysis in ever pregnant women. In sensitivity analyses, we studied men and nulligravidae to investigate genetic liability to HDPs and CVD risk without the ability to experience the underlying phenotype.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Our primary analysis included 221,155 ever pregnant women (mean age 56.8 [SD 7.9]) with available genetic data. Odds ratios for CVD were 1.20 (1.02-1.41) and 1.24 (1.12-1.38) per unit increase in the log odds of genetic liability to pre-eclampsia/eclampsia and gestational hypertension, respectively. Furthermore, genetic liability to HDPs was associated with higher levels of systolic and diastolic blood pressure and younger age at hypertension diagnosis. Sensitivity analyses revealed no statistically significant differences when comparing the findings to those of nulligravidae and men.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Genetic liability to HDPs is associated with higher CVD risk, lower blood pressure levels, and earlier hypertension diagnosis. Our study suggests similar findings in ever pregnant women, nulligravidae and men, implying biological mechanisms relating to HDPs are causally related to CVD risk.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38304335/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240205150914&v=2.18.0">38304335</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC7615585/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240205150914&v=2.18.0">PMC7615585</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad655.2726>10.1093/eurheartj/ehad655.2726</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38304335</guid>
<pubDate>Fri, 02 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Lena Tschiderer</dc:creator>
<dc:creator>Yvonne T van der Schouw</dc:creator>
<dc:creator>Stephen Burgess</dc:creator>
<dc:creator>Kitty Wm Bloemenkamp</dc:creator>
<dc:creator>Lisa Seekircher</dc:creator>
<dc:creator>Peter Willeit</dc:creator>
<dc:creator>N Charlotte Onland-Moret</dc:creator>
<dc:creator>Sanne Ae Peters</dc:creator>
<dc:date>2024-02-02</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Hypertensive disorders of pregnancy and cardiovascular disease risk: A Mendelian Randomisation study</dc:title>
<dc:identifier>pmid:38304335</dc:identifier>
<dc:identifier>pmc:PMC7615585</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad655.2726</dc:identifier>
</item>
<item>
<title>The dark side of arrhythmia treatment: iatrogenic tricuspid regurgitation and drug toxicity</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38302153/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240205150914&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Feb 1;45(5):317-320. doi: 10.1093/eurheartj/ehae026.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38302153/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240205150914&v=2.18.0">38302153</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae026>10.1093/eurheartj/ehae026</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38302153</guid>
<pubDate>Thu, 01 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2024-02-01</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>The dark side of arrhythmia treatment: iatrogenic tricuspid regurgitation and drug toxicity</dc:title>
<dc:identifier>pmid:38302153</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae026</dc:identifier>
</item>
<item>
<title>SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38301646/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240205150914&amp;v=2.18.0
      <description>Genomic instability can trigger cancer-intrinsic innate immune responses that promote tumor rejection. However, cancer cells often evade these responses by overexpressing immune checkpoint regulators, such as PD-L1. Here, we identify the SNF2-family DNA translocase SMARCAL1 as a factor that favors tumor immune evasion by a dual mechanism involving both the suppression of innate immune signaling and the induction of PD-L1-mediated immune checkpoint responses. Mechanistically, SMARCAL1 limits...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jan 25:S0092-8674(24)00010-2. doi: 10.1016/j.cell.2024.01.008. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Genomic instability can trigger cancer-intrinsic innate immune responses that promote tumor rejection. However, cancer cells often evade these responses by overexpressing immune checkpoint regulators, such as PD-L1. Here, we identify the SNF2-family DNA translocase SMARCAL1 as a factor that favors tumor immune evasion by a dual mechanism involving both the suppression of innate immune signaling and the induction of PD-L1-mediated immune checkpoint responses. Mechanistically, SMARCAL1 limits endogenous DNA damage, thereby suppressing cGAS-STING-dependent signaling during cancer cell growth. Simultaneously, it cooperates with the AP-1 family member JUN to maintain chromatin accessibility at a PD-L1 transcriptional regulatory element, thereby promoting PD-L1 expression in cancer cells. SMARCAL1 loss hinders the ability of tumor cells to induce PD-L1 in response to genomic instability, enhances anti-tumor immune responses and sensitizes tumors to immune checkpoint blockade in a mouse melanoma model. Collectively, these studies uncover SMARCAL1 as a promising target for cancer immunotherapy.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38301646/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240205150914&v=2.18.0">38301646</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.01.008>10.1016/j.cell.2024.01.008</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38301646</guid>
<pubDate>Thu, 01 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Giuseppe Leuzzi</dc:creator>
<dc:creator>Alessandro Vasciaveo</dc:creator>
<dc:creator>Angelo Taglialatela</dc:creator>
<dc:creator>Xiao Chen</dc:creator>
<dc:creator>Tessa M Firestone</dc:creator>
<dc:creator>Allison R Hickman</dc:creator>
<dc:creator>Wendy Mao</dc:creator>
<dc:creator>Tanay Thakar</dc:creator>
<dc:creator>Alina Vaitsiankova</dc:creator>
<dc:creator>Jen-Wei Huang</dc:creator>
<dc:creator>Raquel Cuella-Martin</dc:creator>
<dc:creator>Samuel B Hayward</dc:creator>
<dc:creator>Jordan S Kesner</dc:creator>
<dc:creator>Ali Ghasemzadeh</dc:creator>
<dc:creator>Tarun S Nambiar</dc:creator>
<dc:creator>Patricia Ho</dc:creator>
<dc:creator>Alexander Rialdi</dc:creator>
<dc:creator>Maxime Hebrard</dc:creator>
<dc:creator>Yinglu Li</dc:creator>
<dc:creator>Jinmei Gao</dc:creator>
<dc:creator>Saarang Gopinath</dc:creator>
<dc:creator>Oluwatobi A Adeleke</dc:creator>
<dc:creator>Bryan J Venters</dc:creator>
<dc:creator>Charles G Drake</dc:creator>
<dc:creator>Richard Baer</dc:creator>
<dc:creator>Benjamin Izar</dc:creator>
<dc:creator>Ernesto Guccione</dc:creator>
<dc:creator>Michael-Christopher Keogh</dc:creator>
<dc:creator>Raphael Guerois</dc:creator>
<dc:creator>Lu Sun</dc:creator>
<dc:creator>Chao Lu</dc:creator>
<dc:creator>Andrea Califano</dc:creator>
<dc:creator>Alberto Ciccia</dc:creator>
<dc:date>2024-02-01</dc:date>
<dc:source>Cell</dc:source>
<dc:title>SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion</dc:title>
<dc:identifier>pmid:38301646</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.01.008</dc:identifier>
</item>
<item>
<title>PNMA2 forms immunogenic non-enveloped virus-like capsids associated with paraneoplastic neurological syndrome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38301645/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240205150914&amp;v=2.18.0
      <description>The paraneoplastic Ma antigen (PNMA) proteins are associated with cancer-induced paraneoplastic syndromes that present with an autoimmune response and neurological symptoms. Why PNMA proteins are associated with this severe autoimmune disease is unclear. PNMA genes are predominantly expressed in the central nervous system and are ectopically expressed in some tumors. We show that PNMA2, which has been co-opted from a Ty3 retrotransposon, encodes a protein that is released from cells as...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jan 30:S0092-8674(24)00011-4. doi: 10.1016/j.cell.2024.01.009. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The paraneoplastic Ma antigen (PNMA) proteins are associated with cancer-induced paraneoplastic syndromes that present with an autoimmune response and neurological symptoms. Why PNMA proteins are associated with this severe autoimmune disease is unclear. PNMA genes are predominantly expressed in the central nervous system and are ectopically expressed in some tumors. We show that PNMA2, which has been co-opted from a Ty3 retrotransposon, encodes a protein that is released from cells as non-enveloped virus-like capsids. Recombinant PNMA2 capsids injected into mice induce autoantibodies that preferentially bind external "spike" PNMA2 capsid epitopes, whereas a capsid-assembly-defective PNMA2 protein is not immunogenic. PNMA2 autoantibodies in cerebrospinal fluid of patients with anti-Ma2 paraneoplastic disease show similar preferential binding to spike capsid epitopes. PNMA2 capsid-injected mice develop learning and memory deficits. These observations suggest that PNMA2 capsids act as an extracellular antigen, capable of generating an autoimmune response that results in neurological deficits.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38301645/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240205150914&v=2.18.0">38301645</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.01.009>10.1016/j.cell.2024.01.009</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38301645</guid>
<pubDate>Thu, 01 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Junjie Xu</dc:creator>
<dc:creator>Simon Erlendsson</dc:creator>
<dc:creator>Manvendra Singh</dc:creator>
<dc:creator>G Aaron Holling</dc:creator>
<dc:creator>Matthew Regier</dc:creator>
<dc:creator>Iosune Ibiricu</dc:creator>
<dc:creator>Jenifer Einstein</dc:creator>
<dc:creator>Michael P Hantak</dc:creator>
<dc:creator>Gregory S Day</dc:creator>
<dc:creator>Amanda L Piquet</dc:creator>
<dc:creator>Tammy L Smith</dc:creator>
<dc:creator>Stacey L Clardy</dc:creator>
<dc:creator>Alexandra M Whiteley</dc:creator>
<dc:creator>Cédric Feschotte</dc:creator>
<dc:creator>John A G Briggs</dc:creator>
<dc:creator>Jason D Shepherd</dc:creator>
<dc:date>2024-02-01</dc:date>
<dc:source>Cell</dc:source>
<dc:title>PNMA2 forms immunogenic non-enveloped virus-like capsids associated with paraneoplastic neurological syndrome</dc:title>
<dc:identifier>pmid:38301645</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.01.009</dc:identifier>
</item>
<item>
<title>Seeking for Regulatory Mechanisms of Phospholamban Expression</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38300986/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240205150914&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Feb 2;134(3):266-268. doi: 10.1161/CIRCRESAHA.124.324109. Epub 2024 Feb 1.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38300986/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240205150914&v=2.18.0">38300986</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.324109>10.1161/CIRCRESAHA.124.324109</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38300986</guid>
<pubDate>Thu, 01 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Cecilia Mundiña-Weilenmann</dc:creator>
<dc:date>2024-02-01</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Seeking for Regulatory Mechanisms of Phospholamban Expression</dc:title>
<dc:identifier>pmid:38300986</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.324109</dc:identifier>
</item>





























</channel>
</rss>